Foresta Group Holding (FGH) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
8 Jan, 2026Executive summary
Secured a 30-year lease for industrial land in Kawerau, NZ, to establish a flagship manufacturing facility for bio-based energy and chemicals, with resource consents and plant design underway pending funding.
Signed major offtake and supply agreements, including a 10-year contract with TERL for torrefied wood pellets and a 5-year renewable agreement with AV Pound for pine chemicals.
Raised $2.33M in October 2023 and $1.06M in May 2024 to accelerate project development; further $1.1M raised in November 2024 and convertible notes totaling $2.575M post year-end.
Board changes included the resignation of the Managing Director and appointment of a new Non-Executive Director in July 2024.
Financial highlights
Reported a net loss of $9,650,145 for FY24, compared to a $8,206,788 loss in FY23.
Revenue from contracts with customers was $15,792; insurance recoveries totaled $1,830,956.
Negative cash flows from operating activities of $4,073,919, up from $3,461,111 in FY23.
Cash and cash equivalents at year-end were $185,748, down from $1,439,582.
Significant impairments: $6.6M on assets, including scrapping of extraction plant and write-downs at Apple Tree Creek and Landsborough.
Outlook and guidance
Focus for FY25 is securing project funding and advancing the Kawerau facility.
Management remains committed to strategic goals but acknowledges material uncertainty regarding going concern due to ongoing losses and funding needs.
Latest events from Foresta Group Holding
- Losses widened despite higher revenue and cash, with funding and legal risks persisting.FGH
H1 20265 Mar 2026 - Advanced Kawerau project but faces urgent capital needs with less than two quarters' cash.FGH
Q4 2024 TU8 Jan 2026 - Flagship project gains fast-track status as cash reserves fall and capital raising intensifies.FGH
Q1 2025 TU8 Jan 2026 - Convertible note and equity raise boost liquidity, but funding runway remains tight.FGH
Q2 2025 TU8 Jan 2026 - Loss narrowed, funding secured, and NZ project fast-tracked, but going concern risk persists.FGH
H1 20258 Jan 2026 - Flagship biomass project advanced, losses narrowed, capital raised, and fast-track status secured.FGH
H2 20258 Jan 2026 - Major project milestones achieved and $2M raised, enabling next phase of development.FGH
Q3 2025 TU8 Jan 2026 - Regulatory extension and geothermal collaboration drive project progress amid tight cash runway.FGH
Q4 2025 TU8 Jan 2026 - Final $2.4M insurance settlement boosts cash to $2.82M; Kawerau Plant advances.FGH
Q1 2026 TU8 Jan 2026